Dimitrios Giannis
- Infectious Diseases top 1%
- Oncology top 5%
- Neurology top 2%
- Internal Medicine top 1%
- Surgery top 10%
- Co-authors
- Ioannis A. ZiogasPanagiota GianniAlex C. SpyropoulosJames D. DouketisBeverley J. HuntJecko ThachilJean M. ConnorsToshiaki Iba
- Topics
- COVID-19 Clinical Research Studies (14 papers)COVID-19 and healthcare impacts (13 papers)Venous Thromboembolism Diagnosis and Management (10 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesGreeceUnited Kingdom
In The Last Decade
Dimitrios Giannis
51 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Infectious Diseases 1.0k
- Oncology 567
- Neurology 468
- Internal Medicine 467
- Surgery 367
Countries citing papers authored by Dimitrios Giannis
This map shows the geographic impact of Dimitrios Giannis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitrios Giannis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitrios Giannis more than expected).
Fields of papers citing papers by Dimitrios Giannis
This network shows the impact of papers produced by Dimitrios Giannis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitrios Giannis. The network helps show where Dimitrios Giannis may publish in the future.
Co-authorship network of co-authors of Dimitrios Giannis
This figure shows the co-authorship network connecting the top 25 collaborators of Dimitrios Giannis. A scholar is included among the top collaborators of Dimitrios Giannis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitrios Giannis. Dimitrios Giannis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | Safety profile of chloroquine and hydroxychloroquine: a disproportionality analysis of the FDA Adverse Event Reporting System database | 3 |
| 5 | 14 | |
| 6 | 27 | |
| 7 | 2 | |
| 8 | 30 | |
| 9 | 25 | |
| 10 | 5 | |
| 11 | 9 | |
| 12 | 5 | |
| 13 | 3 | |
| 14 | 6 | |
| 15 | Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19breakdown → | 440 |
| 16 | 37 | |
| 17 | 2 | |
| 18 | Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the pastbreakdown → | 633 |
| 19 | Insulinomas: from diagnosis to treatment. A review of the literature. | 33 |
| 20 | 10 |
About Dimitrios Giannis
Dimitrios Giannis is a scholar working on Internal Medicine, Oncology and Infectious Diseases, having authored 56 papers that have together received 1.8k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (14 papers), COVID-19 and healthcare impacts (13 papers) and Venous Thromboembolism Diagnosis and Management (10 papers). The work is most often cited by research in Internal Medicine (467 citations), Infectious Diseases (1.0k citations) and Neurology (468 citations). Dimitrios Giannis has collaborated with scholars based in United States, Greece and United Kingdom. Frequent co-authors include Ioannis A. Ziogas, Panagiota Gianni, Alex C. Spyropoulos, James D. Douketis, Beverley J. Hunt, Jecko Thachil, Jean M. Connors, Toshiaki Iba, Dimitrios Moris and Marcel Levi. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.